Literature DB >> 7986142

Candida colonization and subsequent infections in critically ill surgical patients.

D Pittet1, M Monod, P M Suter, E Frenk, R Auckenthaler.   

Abstract

OBJECTIVE: The authors determined the role of Candida colonization in the development of subsequent infection in critically ill patients.
DESIGN: A 6-month prospective cohort study was given to patients admitted to the surgical and neonatal intensive care units in a 1600-bed university medical center.
METHODS: Patients having predetermined criteria for significant Candida colonization revealed by routine microbiologic surveillance cultures at different body sites were eligible for the study. Risk factors for Candida infection were recorded. A Candida colonization index was determined daily as the ratio of the number of distinct body sites (dbs) colonized with identical strains over the total number of dbs tested; a mean of 5.3 dbs per patient was obtained. All isolates (n = 322) sequentially recovered were characterized by genotyping using contour-clamped homogeneous electrical field gel electrophoresis that allowed strain delineation among Candida species.
RESULTS: Twenty-nine patients met the criteria for inclusion; all were at high risk for Candida infection; 11 patients (38%) developed severe infections (8 candidemia); the remaining 18 patients were heavily colonized, but never required intravenous antifungal therapy. Among the potential risk factors for candida infection, three discriminated the colonized from the infected patients--i.e., length of previous antibiotic therapy (p < 0.02), severity of illness assessed by APACHE II score (p < 0.01), and the intensity of Candida spp colonization (p < 0.01). By logistic regression analysis, the latter two who were the independent factors that predicted subsequent candidal infection. Candida colonization always preceded infection with genotypically identical Candida spp strain. The proposed colonization indexes reached threshold values a mean of 6 days before Candida infection and demonstrated high positive predictive values (66 to 100%).
CONCLUSIONS: The intensity of Candida colonization assessed by systematic screening helps predicting subsequent infections with identical strains in critically ill patients. Accurately identifying high-risk patients with Candida colonization offers opportunity for intervention strategies.

Entities:  

Mesh:

Year:  1994        PMID: 7986142      PMCID: PMC1234477          DOI: 10.1097/00000658-199412000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  27 in total

1.  Nosocomial infection and fatality in medical and surgical intensive care unit patients.

Authors:  D E Craven; L M Kunches; D A Lichtenberg; N R Kollisch; M A Barry; T C Heeren; W R McCabe
Journal:  Arch Intern Med       Date:  1988-05

Review 2.  Candida infections in the intensive care unit.

Authors:  J D Sobel
Journal:  Crit Care Clin       Date:  1988-04       Impact factor: 3.598

3.  Variation of electrophoretic karyotypes among clinical isolates of Candida albicans.

Authors:  W G Merz; C Connelly; P Hieter
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

4.  Problems in the diagnosis and treatment of systemic candidiasis.

Authors:  E Goldstein; P D Hoeprich
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

5.  Risk factors for nosocomial candidemia: a case-control study in adults without leukemia.

Authors:  J Bross; G H Talbot; G Maislin; S Hurwitz; B L Strom
Journal:  Am J Med       Date:  1989-12       Impact factor: 4.965

Review 6.  Candidiasis.

Authors:  F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

7.  Risk factors for hospital-acquired candidemia. A matched case-control study.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1989-10

8.  Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia.

Authors:  A J Morrison; C V Freer; M A Searcy; S M Landry; R P Wenzel
Journal:  Infect Control       Date:  1986-11

9.  Nosocomial fungemia in a large community teaching hospital.

Authors:  R L Harvey; J P Myers
Journal:  Arch Intern Med       Date:  1987-12

10.  A Candida albicans dispersed, repeated gene family and its epidemiologic applications.

Authors:  S Scherer; D A Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  174 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 2.  Infection control in ICU: back (forward) to surveillance samples?

Authors:  M Langer; E Carretto; E A Haeusler
Journal:  Intensive Care Med       Date:  2001-10       Impact factor: 17.440

Review 3.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

4.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 5.  Prophylaxis and treatment of invasive candidiasis in the intensive care setting.

Authors:  L Ostrosky-Zeichner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

6.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 7.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 8.  Management of antimicrobial use in the intensive care unit.

Authors:  Francisco Álvarez-Lerma; Santiago Grau
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

9.  Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.

Authors:  P Pini; C Bettua; C F Orsi; C Venturelli; F Forghieri; S Bigliardi; L Faglioni; F Luppi; L Serio; M Codeluppi; M Luppi; C Mussini; M Girardis; Elisabetta Blasi
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

10.  Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients.

Authors:  Laurence Senn; Philippe Eggimann; Riadh Ksontini; Andres Pascual; Nicolas Demartines; Jacques Bille; Thierry Calandra; Oscar Marchetti
Journal:  Intensive Care Med       Date:  2009-01-27       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.